Get the latest Science News and Discoveries

Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical Trial


The trial will evaluate the effectiveness and safety of a new vaccine compared to an FDA-approved mRNA vaccine. University of Georgia-based startup CyanVac LLC has received federal funding to conduct a Phase 2b clinical trial to compare its intranasal vaccine candidates, CVXGA, which are designed t

None

Get the Android app

Or read this on SciTech Daily

Read more on:

Photo of Federal funding

Federal funding

Photo of COVID-19

COVID-19

Related news:

News photo

NIH-sponsored trial of nasal COVID-19 vaccine opens - EurekAlert

News photo

Common respiratory infections may have protected children from COVID-19, study suggests - EurekAlert

News photo

Federal funding for major science agencies is at a 25-year low